Germline genetic testing in ovarian cancer patients: Identifying barriers to care and opportunities for improvement.

被引：0
|
作者：
Stock, Elizabeth
Cowan, Matthew
Romero, Iris L.
Yamada, Seiko Diane
机构：
[1] Univ Chicago Med, Chicago, IL USA
[2] Northwestern Med, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e13142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13142
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
    Rossella Graffeo
    Luca Livraghi
    Olivia Pagani
    Aron Goldhirsch
    Ann H. Partridge
    Judy E. Garber
    Breast Cancer Research and Treatment, 2016, 160 : 393 - 410
  • [42] Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer
    Whitworth, Pat W.
    Beitsch, Peter D.
    Patel, Rakesh
    Rosen, Barry
    Compagnoni, Gia
    Baron, Paul L.
    Simmons, Rache
    Brown, Eric A.
    Gold, Linsey
    Holmes, Dennis
    Smith, Linda Ann
    Kinney, Michael
    Grady, Ian
    Clark, Patricia
    Barbosa, Karen
    Lyons, Samuel
    Riley, Lee
    Coomer, Cynara
    Curcio, Lisa
    Ruiz, Antonio
    Khan, Sadia
    MacDonald, Heather
    Hughes, Kevin
    Hardwick, Mary Kay
    Heald, Brandie
    Munro, Sandra B.
    Nielsen, Sarah M.
    Esplin, Edward D.
    JAMA NETWORK OPEN, 2022, 5 (09) : E2232787
  • [43] Evidence Grows for Universal Germline Genetic Testing for Patients with Breast Cancer
    不详
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2023, 191 (02) : 319 - 320
  • [44] Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake
    Mitchell L. Ramsey
    Jewel Tomlinson
    Rachel Pearlman
    Laith Abushahin
    Amber Aeilts
    Hui-Zi Chen
    Yan Chen
    Ashley Compton
    Rifat Elkhatib
    Levi Geiger
    John Hays
    Joanne Jeter
    Ning Jin
    Pannaga Malalur
    Sameek Roychowdhury
    Jessica Ruple
    Jennifer Prebish
    Peter P. Stanich
    Heather Hampel
    Familial Cancer, 2023, 22 : 91 - 97
  • [45] Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake
    Ramsey, Mitchell L.
    Tomlinson, Jewel
    Pearlman, Rachel
    Abushahin, Laith
    Aeilts, Amber
    Chen, Hui-Zi
    Chen, Yan
    Compton, Ashley
    Elkhatib, Rifat
    Geiger, Levi
    Hays, John
    Jeter, Joanne
    Jin, Ning
    Malalur, Pannaga
    Roychowdhury, Sameek
    Ruple, Jessica
    Prebish, Jennifer
    Stanich, Peter P.
    Hampel, Heather
    FAMILIAL CANCER, 2023, 22 (01) : 91 - 97
  • [46] Genetic testing and management of prostate cancer patients with pathogenic germline variants
    Reiter, Katharina
    Hassler, Melanie R.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (01) : 51 - 56
  • [47] Germline genetic testing for breast cancer: which patients? What genes?
    Domchek, Susan M.
    GENETICS IN MEDICINE, 2020, 22 (04) : 698 - 700
  • [48] Germline testing for predisposition to breast/ovarian cancer should only be offered to selected patients with epithelial ovarian cancer
    Nag S.
    Sinukumar S.
    Hegde S.
    Indian Journal of Gynecologic Oncology, 2017, 15 (Suppl 1) : S31 - S36
  • [49] Clinical utility of universal germline genetic testing for patients with breast cancer
    Whitworth, Pat
    Beitsch, Peter
    Hardwick, Mary Kay
    Wernecke, Chloe
    Grady, Ian
    Barbosa, Karen
    Patel, Rakesh
    Kinney, Michael
    Baron, Paul
    Rosen, Barry
    Compagnoni, Gia
    Smith, Linda
    Simmons, Rache
    Coomer, Cynara
    Holmes, Dennis
    Brown, Eric
    Gold, Linsey
    Curcio, Lisa
    Clark, Patricia
    Ruiz, Antonio
    MacDonald, Heather
    Khan, Sadia
    Riley, Lee
    Lyons, Samuel
    Hughes, Kevin
    Nussbaum, Robert
    Munro, Sandra
    Nielsen, Sarah
    Esplin, Edward
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 137 - 138
  • [50] Genetic testing and management of prostate cancer patients with pathogenic germline variants
    Katharina Reiter
    Melanie R. Hassler
    memo - Magazine of European Medical Oncology, 2024, 17 : 51 - 56
12345